Barry Canton - 10%+ Owner at Ginkgo Bioworks Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Stock Symbol
DNA, DNA-WT on NYSE, DNABW on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Barry Canton - trading volume in the past year for Ginkgo Bioworks Holdings, Inc.

Holdings reported by Barry Canton for Ginkgo Bioworks Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class B Common Stock 70.2M $122M $1.74 Dec 8, 2023 By Reshma Padmini Shetty Living Trust Class A Common Stock 70.2M
Class B Common Stock 70M $122M $1.74 Dec 8, 2023 By Bartholomew Canton Living Trust Class A Common Stock
Class A Common Stock 12.4M $19.2M $1.56 Dec 20, 2023 By Spouse
Class A Common Stock 12.4M $19.2M $1.56 Dec 21, 2023 Direct
Class B Common Stock 8.25M $14.3M $1.74 Dec 8, 2023 By Bartholomew Canton GRAT Class A Common Stock 8.25M
Class B Common Stock 8.25M $14.3M $1.74 Dec 8, 2023 By Reshma Padmini Shetty GRAT Class A Common Stock 8.25M
Class B Common Stock 2.32M $4.03M $1.74 Dec 8, 2023 By Spouse Class A Common Stock 2.32M
Class B Common Stock 2.32M $4.03M $1.74 Dec 8, 2023 Direct Class A Common Stock 2.32M
Class B Common Stock 1.29M $2.24M $1.74 Dec 8, 2023 By The Adhira S. Canton Irrevocable Trust Class A Common Stock 1.29M
Class B Common Stock 1.29M $2.24M $1.74 Dec 8, 2023 By The Asha S. Canton Irrevocable Trust Class A Common Stock 1.29M
Stock Option 5M Apr 25, 2024 By Spouse Class A Common Stock
Stock Option 5M Apr 25, 2024 Direct Class A Common Stock

Transactions reported by Barry Canton for Ginkgo Bioworks Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.